A N Nyantika1, T-P Tuomainen, J Kauhanen, S Voutilainen, J K Virtanen. 1. Jyrki K. Virtanen, University of Eastern Finland, Kuopio Campus, Institute of Public Health and Clinical Nutrition, PO Box 1627, 70211 Kuopio, Finland, +358 (0) 294454542 / +358 (0) 403552957 Fax +358-17-162936. E-mail: jyrki.virtanen@uef.fi.
Abstract
OBJECTIVES: To investigate the associations of serum long-chain omega-3 polyunsaturated fatty acids (PUFA) and hair mercury with future blood pressure in an ageing population. DESIGN: Prospective study with baseline measurements in 1998-2001 and follow-up measurements in 2005-2008. The linear relationships (β) of baseline serum fatty acids and hair mercury with future systolic and diastolic blood pressure and pulse pressure were analyzed with multiple linear regression models, using log-transformed values. PARTICIPANTS: 181 men and 200 women aged 53-73 y from the Kuopio Ischemic Heart Disease Risk Factor Study (KIHD) population in Eastern Finland, who were free of cardiovascular disease, diabetes or hypertension at baseline. MEASUREMENTS: Total serum esterified and nonesterified fatty acids and pubic hair mercury were used as markers for exposure. Anthropometric and other lifestyle and health-related data were collected. RESULTS: The mean serum concentrations were 1.67% (SD 0.92) for eicosapentaenoic acid (EPA), 0.79% (SD 0.16) for docosapentaenoic acid (DPA) and 2.78 (SD 0.92) for docosahexaenoic acid (DHA), of all serum fatty acids. The mean hair mercury concentration was 1.5 µg/g (SD 1.6). We did not find statistically significant associations between the baseline serum long-chain omega-3 PUFA concentrations or hair mercury content and future blood pressure. Hair mercury did not modify the associations with the long-chain omega-3 PUFAs, either. CONCLUSIONS: Higher serum long-chain omega-3 PUFA concentration, a biomarker of fish or fish oil consumption, may not have an impact on future blood pressure in an ageing population.
OBJECTIVES: To investigate the associations of serum long-chain omega-3 polyunsaturated fatty acids (PUFA) and hair mercury with future blood pressure in an ageing population. DESIGN: Prospective study with baseline measurements in 1998-2001 and follow-up measurements in 2005-2008. The linear relationships (β) of baseline serum fatty acids and hair mercury with future systolic and diastolic blood pressure and pulse pressure were analyzed with multiple linear regression models, using log-transformed values. PARTICIPANTS: 181 men and 200 women aged 53-73 y from the Kuopio Ischemic Heart Disease Risk Factor Study (KIHD) population in Eastern Finland, who were free of cardiovascular disease, diabetes or hypertension at baseline. MEASUREMENTS: Total serum esterified and nonesterified fatty acids and pubic hair mercury were used as markers for exposure. Anthropometric and other lifestyle and health-related data were collected. RESULTS: The mean serum concentrations were 1.67% (SD 0.92) for eicosapentaenoic acid (EPA), 0.79% (SD 0.16) for docosapentaenoic acid (DPA) and 2.78 (SD 0.92) for docosahexaenoic acid (DHA), of all serum fatty acids. The mean hair mercury concentration was 1.5 µg/g (SD 1.6). We did not find statistically significant associations between the baseline serum long-chain omega-3 PUFA concentrations or hair mercury content and future blood pressure. Hair mercury did not modify the associations with the long-chain omega-3 PUFAs, either. CONCLUSIONS: Higher serum long-chain omega-3 PUFA concentration, a biomarker of fish or fish oil consumption, may not have an impact on future blood pressure in an ageing population.
Authors: P Xun; N Hou; M Daviglus; K Liu; J S Morris; J M Shikany; S Sidney; D R Jacobs; K He Journal: J Intern Med Date: 2011-01-09 Impact factor: 8.989
Authors: Jyrki K Virtanen; Sari Voutilainen; Tiina H Rissanen; Jaakko Mursu; Tomi-Pekka Tuomainen; Maarit J Korhonen; Veli-Pekka Valkonen; Kari Seppänen; Jari A Laukkanen; Jukka T Salonen Journal: Arterioscler Thromb Vasc Biol Date: 2004-11-11 Impact factor: 8.311
Authors: Jyrki K Virtanen; Asenath N Nyantika; Jussi Kauhanen; Sari Voutilainen; Tomi-Pekka Tuomainen Journal: Hypertens Res Date: 2012-06-07 Impact factor: 3.872
Authors: P Pauletto; M Puato; M G Caroli; E Casiglia; A E Munhambo; G Cazzolato; G Bittolo Bon; M T Angeli; C Galli; A C Pessina Journal: Lancet Date: 1996-09-21 Impact factor: 79.321
Authors: Dariush Mozaffarian; Peilin Shi; J Steven Morris; Philippe Grandjean; David S Siscovick; Donna Spiegelman; Walter C Willett; Eric B Rimm; Gary C Curhan; John P Forman Journal: Hypertension Date: 2012-08-06 Impact factor: 10.190
Authors: D E Laaksonen; T A Lakka; H-M Lakka; K Nyyssönen; T Rissanen; L K Niskanen; J T Salonen Journal: Diabet Med Date: 2002-06 Impact factor: 4.359
Authors: Henry A Roman; Tyra L Walsh; Brent A Coull; Éric Dewailly; Eliseo Guallar; Dale Hattis; Koenraad Mariën; Joel Schwartz; Alan H Stern; Jyrki K Virtanen; Glenn Rice Journal: Environ Health Perspect Date: 2011-01-10 Impact factor: 9.031
Authors: Anna L Choi; Pal Weihe; Esben Budtz-Jørgensen; Poul J Jørgensen; Jukka T Salonen; Tomi-Pekka Tuomainen; Katsuyuki Murata; Hans Petur Nielsen; Maria Skaalum Petersen; Jórun Askham; Philippe Grandjean Journal: Environ Health Perspect Date: 2008-10-16 Impact factor: 9.031
Authors: Asenath N Nyantika; Tomi-Pekka Tuomainen; Jussi Kauhanen; Sari Voutilainen; Jyrki K Virtanen Journal: Hypertens Res Date: 2016-02-25 Impact factor: 3.872
Authors: L Su; Y Jin; F W Unverzagt; C Liang; Y Cheng; A M Hake; D Kuruppu; F Ma; J Liu; C Chen; J Bian; P Li; S Gao Journal: J Nutr Health Aging Date: 2016 Impact factor: 4.075